The Patent Finder

Nanjing Genscript Biotech Co., Ltd.

33 patents currently held · Updated Nov 15, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Nanjingjinsirui Science & Technology Biology Corp. (to 2020)

3
Ending by 2030
May 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 23, 2026
    The maintenance fee for Gel electrophoresis device for loading large sample volumes (US 9,061,236) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
  • 1 fee due Jan 28, 2027
    The maintenance fee for Antibody humanization by framework assembly (US 9,090,994) comes due Jan 28, 2027. Unpaid by Jul 28, 2027, it lapses early.
  • 1 fee due May 5, 2027
    The maintenance fee for Multimer of mutant protein A and methods of using same (US 10,464,972) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Fusion Protein Dimer Using Antibody FC Region as Backbone and Use Thereof (US 11,970,537) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 4 of the patents on this record were granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,816,092Rapid C-ELISA process and related compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,824,867Rapid ELISA processes and related compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,501,454Homologous recombination-based DNA cloning compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,815,600Homologous recombination-based DNA cloning methods and compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,060,878System for rapid electrophoresis binding method and related kits and compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,090,994Antibody humanization by framework assembly
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,968,541Rapid electrophoresis binding method and related kits and compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,603,780Methods and compositions for enhanced expression and secretion of proteins
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,287,327Protein a Mutants Having High Alkali Resistance and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 10,464,972Multimer of mutant protein A and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
Also on record, not counted in the 33: 1 patent in force now held by others · 2 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

22 pending · 3 abandoned · 15 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited